Wells Fargo & Company »

TherapeuticsMD shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $238 144 1.66
2024-06-30 $275 171 1.61
2024-03-31 $611 267 2.29
2023-12-31 $720 320 2.25
2023-09-30 $996 330 3.02
2023-06-30 $1.5k 355 4.12
2022-12-31 $2.3k 408 5.59
2022-09-30 $0 486 0.00
2022-06-30 $0 431 0.00